Scolaris Content Display Scolaris Content Display

Analgésicos tópicos para el dolor agudo y crónico en pacientes adultos: un resumen de revisiones Cochrane

Contraer todo Desplegar todo

Referencias

Cameron 2011

Cameron M, Gagnier JJ, Chrubasik S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD002948.pub2]

Cameron 2013

Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD010538]

Cui 2010

Cui X, Trinh K, Wang YJ. Chinese herbal medicine for chronic neck pain due to cervical degenerative disc disease. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006556.pub2]

Cumpston 2009

Cumpston M, Johnston RV, Wengier L, Buchbinder R. Topical glyceryl trinitrate for rotator cuff disease. Cochrane Database of Systematic Reviews 2009, Issue 310.1002/14651858.CD006355.pub2. [DOI: 10.1002/14651858.CD006355.pub2]

Derry 2012

Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010111]

Derry 2014a

Derry S, Wiffen PJ, Moore RA, Quinlan J. Topical lidocaine for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI: 10.1002/14651858.CD010958.pub2]

Derry 2014b

Derry S, Matthews PRL, Wiffen PJ, Moore RA. Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD007403.pub3]

Derry 2015

Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD007402.pub3]

Derry 2016

Derry S, Conaghan P, Da Silva JAP, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD007400.pub3]

Derry 2017

Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD007393.pub4]

Otlean 2014

Oltean H, Robbins C, Van Tulder MW, Berman BM, Bombardier C, Gagnier JJ. Herbal medicine for low‐back pain. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD004504.pub4]

Pattanittum 2013

Pattanittum P, Turner T, Green S, Buchbinder R. Non‐steroidal anti‐inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD003686.pub2]

Wrzosek 2015

Wrzosek A, Woron J, Dobrogowski J, Jakowicka‐Wordliczek J, Wordliczek J. Topical clonidine for neuropathic pain. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD010967.pub2]

Johnston 2007

Johnston RV, Buchbinder R, Green S, Assendelft WJJ, Smidt N. Topical glyceryl trinitrate for lateral elbow pain. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD006350]

AlBalawi 2013

AlBalawi Z, McAlister FA, Thorlund K, Wong M, Wetterslev J. Random error in cardiovascular meta‐analyses: how common are false positive and false negative results?. International Journal of Cardiology 2013;168(2):1102‐7. [DOI: 10.1016/j.ijcard.2012.11.048]

Anand 2011

Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high‐concentration capsaicin 8% patch. British Journal of Anaesthetics 2011;107(4):490‐502. [DOI: 10.1093/bja/aer260]

Attal 2010

Attal N1, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology 2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x]

Cook 1995

Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ (Clinical Research Ed) 1995;310:452‐4.

Dechartres 2013

Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta‐epidemiological study. BMJ 2013;346:f2304. [DOI: 10.1136/bmj.f2304]

Dechartres 2014

Dechartres A, Altman DG, Trinquart L, Boutron I, Ravaud P. Association between analytic strategy and estimates of treatment outcomes in meta‐analyses. JAMA 2014;312(6):623‐30. [DOI: 10.1001/jama.2014.8166]

Derry 2001

Derry S, Loke YK, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Medical Research Methodology 2001;1:7. [DOI: 10.1186/1471‐2288‐1‐7]

Edwards 1999

Edwards JE, McQuay HJ, Moore RA, Collins SL. Reporting of adverse effects in clinical trials should be improved: lessons from acute postoperative pain. Journal of Pain and Symptom Management 1999;18(6):427‐37.

EPOC 2015

Effective Practice, Organisation of Care (EPOC). 23. Worksheets for preparing Summary of Findings tables using GRADE. Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services. Available at: epoc.cochrane.org/epoc‐specific‐resources‐review‐authors (accessed 3 March 2017)2015.

Evans 1995

Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, et al. Topical non‐steroidal anti‐inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case‐control study. BMJ 1995;311(6996):22‐6. [DOI: 10.1136/bmj.311.6996.22]

Finnerup 2015

Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta‐analysis. Lancet Neurology 2015;14(2):162‐73. [DOI: 10.1016/S1474‐4422(14)70251‐0]

Fitzgerald 2001

FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase‐2. New England Journal of Medicine 2001;345(6):433‐42. [DOI: 10.1056/NEJM200108093450607]

Gaskell 2014

Gaskell H, Derry S, Moore RA. Treating chronic non‐cancer pain in older people‐‐more questions than answers?. Maturitas 2014;79(1):34‐40. [DOI: 10.1016/j.maturitas.2014.06.013]

Guyatt 2011

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence‐‐inconsistency. Journal of Cinical Epidemiology 2011;64(12):1294‐302. [DOI: 10.1016/j.jclinepi.2011.03.017]

Guyatt 2013a

Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso‐Coello P, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology 2013;66(2):151‐7. [DOI: 10.1016/j.jclinepi.2012.01.006]

Guyatt 2013b

Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE guidelines: 12. Preparing summary of findings tables‐binary outcomes. Journal of Clinical Epidemiology 2013;66(2):158‐72. [DOI: 10.1016/j.jclinepi.2012.01.012]

Hawkey 1999

Hawkey CJ. Cox‐2 inhibitors. Lancet 1999;353(9149):307‐14. [DOI: 10.1016/S0140‐6736(98)12154‐2]

Higgins 2011

Higgins JPT, Green S (editors). Chapter 4: Guide to the contents of a Cochrane protocol and review. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Hochberg 2012

Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care and Research 2012;64(4):465‐74. [DOI: 10.1002/acr.21596]

Kammers 2010

Kammers MP, de Vignemont F, Haggard P. Cooling the thermal grill illusion through self‐touch. Current Biology 2010;20(20):1819‐22. [DOI: 10.1016/j.cub.2010.08.038]

Khaliq 2007

Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD004846.pub2]

Martindale 2016

Capsaicin. Martindale: the complete drug reference. Available at: www.medicinescomplete.com/mc/martindale/current/ (accessed 3 March 2017).

Moore 1998

Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209‐16. [DOI: 10.1016/S0304‐3959(98)00140‐7]

Moore 2008a

Moore RA, Derry S, McQuay HJ. Topical agents in the treatment of rheumatic pain. Rheumatic Diseases Clinics of North America 2008;34(2):415‐32. [DOI: 10.1016/j.rdc.2008.03.006]

Moore 2008b

Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15‐24. [ISBN: 978‐0‐931092‐69‐5]

Moore 2010a

Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews [for the ACTINPAIN writing group of the IASP Special Interest Group (SIG) on Systematic Reviews in Pain Relief and the Cochrane Pain, Palliative and Supportive Care Systematic Review Group editors]. Pain 2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011]

Moore 2010b

Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374‐9. [DOI: 10.1136/ard.2009.107805]

Moore 2010c

Moore RA, Derry S, McQuay HJ, Straube S, Aldington D, Wiffen P, et al. Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain 2010;149(2):173‐6. [DOI: 10.1016/j.pain.2009.08.007]

Moore 2012

Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004]

Moore 2013a

Moore RA, Straube S, Aldington D. Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple, universal outcome. Anaesthesia 2013;68(4):400‐12. [DOI: 10.1111/anae.12148]

Moore 2013b

Moore A, Derry S, Eccleston C, Kalso E. Expect analgesic failure; pursue analgesic success. BMJ 2013;346:f2690. [DOI: 10.1136/bmj.f2690]

Moore 2013c

Moore RA. What works for whom? Determining the efficacy and harm of treatments for pain. Pain 2013;154(Suppl 1):S77‐S86. [DOI: 10.1016/j.pain.2013.03.024]

Moore 2014

Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice 2014;14(1):79‐94. [DOI: 10.1111/papr.12050]

Moore 2015

Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD008659.pub3]

Morris 1995

Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics with Confidence ‐ Confidence Intervals and Statistical Guidelines. London: BMJ, 1995:50‐63.

Morton 2002

Morton I, Hall J. The Royal Society of Medicine: Medicines. 6th Edition. London: Bloomsbury, 2002.

NICE 2013

National Institute for Health and Care Excellence. Neuropathic pain – pharmacological management: the pharmacological management of neuropathic pain in adults in non‐specialist settings. www.nice.org.uk/guidance/CG173 (accessed 1 August 2014). [www.nice.org.uk/nicemedia/live/13566/64189/64189.pdf ]

NICE 2014

National Institute for Health and Care Excellence. Osteoarthritis: Care and management in adults. NICE clinical guideline 177 (guidance.nice.org.uk/cg177). London: Royal College of Physicians, 2014. [ISBN: 978‐1‐4731‐0426‐6]

Nüesch 2010

Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ 2010;341:c3515. [DOI: 10.1136/bmj.c3515]

PaPaS 2012

PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 3 March 2017).

Sawynok 2014

Sawynok J. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development. European Journal of Pain 2014;18(4):465‐81. [DOI: 10.1002/j.1532‐2149.2013.00400.x]

Schünemann 2011

Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Shea 2007

Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;7:10. [DOI: 10.1186/1471‐2288‐7‐10]

Thorlund 2011

Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta‐analysis‐‐a simulation study. PLoS One 2011;6(10):e25491. [DOI: 10.1371/journal.pone.0025491]

Thornton 2000

Thornton A, Lee P. Publication bias in meta‐analysis: its causes and consequences. Journal of Clinical Epidemiology 2000;53(2):207‐16. [DOI: 10.1016/S0895‐4356(99)00161‐4]

Tramèr 2004

Tramèr MR. It's not just about rubbing—topical capsaicin and topical salicylates may be useful as adjuvants to conventional pain treatment. BMJ 2004;328(7446):998. [DOI: 10.1136/bmj.328.7446.998]

Turner 2013

Turner RM, Bird SM, Higgins JP. The impact of study size on meta‐analyses: examination of underpowered studies in Cochrane Reviews. PLoS One 2013;8(3):e59202. [DOI: 10.1371/journal.pone.0059202]

Vos 2012

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2163‐96. [DOI: 10.1016/S0140‐6736(12)61729‐2]

Wehrfritz 2011

Wehrfritz A, Namer B, Ihmsen H, Mueller C, Filitz J, Koppert W, et al. Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin. European Journal of Pain 2011;15(9):907‐12. [DOI: 10.1016/j.ejpain.2011.03.011]

Zorzela 2014

Zorzela L, Golder S, Liu Y, Pilkington K, Hartling L, Joffe A, et al. Quality of reporting in systematic reviews of adverse events: systematic review. BMJ 2014;348:f7668. [DOI: 10.1136/bmj.f7668]

References to other published versions of this review

Moore 2010

Moore RA, Derry S, McQuay HJ. Topical analgesics for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD008609]